| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |